Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9607 posts found.

New HIV prevention drug application submitted to FDA

May 5, 2021 Research and Development FDA, HIV

ViiV Healthcare have initiated a rolling submission of a new drug application (NDA) with the FDA for their long-acting HIV …
News
COVID-19 virus

Pharmafile.com’s weekly COVID-19 news round-up

April 28, 2021 Research and Development COVID-19, covid 19 news, covid-19 news, news roundup, pharma, pharma news

The past week has seen plenty of COVID-19 news continue to roll in: The European Commission has sued AstraZeneca over …
News

COVID Symptom Study app reveals most common vaccine side effects

April 28, 2021 Research and Development COVID-19, Vaccine, data

An analysis of over 600,000 people’s vaccine reports has been published in The Lancet Infectious Diseases journal, in the largest …
News

Calliditas’ kidney disease drug granted priority review by FDA

April 28, 2021 Research and Development Calliditas, FDA, nephropathy, pharma, pharma news

The FDA has granted priority review for the New Drug Applicaton (NDA) for Calliditas Therapeutics’ Nefecon, for the treatment of …
News

NICE to join GetReal Institute alongside nine key healthcare players

April 28, 2021 Research and Development EU, NICE, rwe

NICE has announced it will join with nine other organisations to form the GetReal Institute, a not-for-profit multi-stakeholder enterprise, as …
News

Single dose of COVID vaccine can cut transmissions in half

April 28, 2021 Research and Development COVID-19, Public Health England, Vaccine

A Public Health England (PHE) study into the Pfizer-BioNTech and Oxford-AstraZeneca vaccines has found that a single dose of either …
News
download_2

Sheila Frame new President for the Americas at Amryt

April 27, 2021 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Biopharmaceutical company Amryt have appointed Sheila Frame as President for the Americas.
Appointment
download_1

Francesco Maria Lavino appointed CEO of F2G Ltd

April 27, 2021 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

F2G Limited has announced that Francesco Maria Lavino has been appointed Chief Executive Officer and member of the Board of …
Appointment
download

Macrogen Europe appoints Dr Bongcho Kim as new CEO

April 27, 2021 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Macrogen Europe have announced the appointment of a new CEO, Dr Bongcho Kim, who joins the company after a successful …
Appointment

King & Spalding announce appointment of former FDA official

April 27, 2021 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Eva Temkin, a former senior FDA official for therapeutic biologics and biosimilars, has joined King & Spalding in Washington, US, …
Appointment

Are we on the cusp of an AI revolution?

April 27, 2021 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

The pharmaceutical industry has historically been slow to adapt to change, with high regulatory hurdles and widespread scepticism facing new …
Feature

Navigating through the post-COVID-19 R&D bottleneck

April 27, 2021 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Jack Goddard inve
Feature
COVID-19 virus

Pharmafile.com’s weekly COVID-19 news round-up

April 21, 2021 Research and Development COVID-19, COVID-19 vaccine, covid 19 news, covid-19 news, pharma, pharma news

The past week has seen lots of COVID-19 developments; Avacta’s 20-minute COVID test has gained clinical validation, the EMA has …
News
Amgen flag

Amgen stomach cancer drug awarded Breakthrough Therapy Designation

April 21, 2021 Research and Development Amgen, Cancer, cancer treatment, pharma, pharma news

Amgen’s investigational therapy, bemarituzumab, for certain types of stomach and esophagus cancer, has been granted Breakthrough Therapy Designation by the …
News

J&J COVID-19 vaccine to resume Europe rollout

April 21, 2021 Research and Development COVID-19, COVID-19 vaccine, J&J, J&J vaccine, JJ, pharma, pharma news

The Johnson & Johnson COVID-19 vaccine will continue its rollout in Europe, following a review from the EMA.
News
The Gateway to Local Adoption Series

Latest content

Secarna appoints Jens Holstein and Richard Mark Engelhard to new Advisory Board

March 25, 2026

Roche adds 2,176 NVIDIA Blackwell GPUs to its hybrid-cloud AI factory

March 25, 2026

ReproNovo appoints Mark Altmeyer as Chairman of the Board

March 24, 2026

EndoCyclic New Drug application approved by US FDA for endometriosis treatment

March 24, 2026

Mestag Therapeutics appoints Lindsey Rolfe as Chief Medical Officer and Pascal Merchiers as Chief Development Officer

March 23, 2026